8-9 November 2018, London, UK
Oxford Global is proud to present its 4th Annual Genome Editing Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
Our Genome Editing Congress will feature over 20 presentations and case studies focused on the latest developments in gene editing techniques and case studies on the therapeutic applications of genome editing technologies.
World-renowned experts will give over 20 presentations across 2 interactive streams, including;
View the Agenda here>> https://bit.ly/2s1kWe7
This event will be co-located with the highly established 10th Annual Next Generation Sequencing and Clinical Diagnostics Congress, 6th Annual Single Cell Analysis Congress and the Synthetic Biology Congress.
Approaching CRISPR Intellectual Property Issues
Hosted by Catherine Coombes, Patent Director, HGF Limited
Register for free today: https://bit.ly/2J2gR0s
Design, Deliver & Detect: Considerations For Optimized In Vitro And Ex Vivo CRISPR Applications.
Hosted by Eric Paul Bennett, Associate Professor, University of Copenhagen
Register for free today: https://bit.ly/2IUsHxL
Can’t make the date? Register today and the recording of the webinar will be sent to you afterward.
For further information, prices & group discounts please contact firstname.lastname@example.org